- Home
- PAYP vs QGEN Comparison
PAYP vs QGEN Comparison
Compare PAYP & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAYP | QGEN |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | Japan | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 8.7B |
| IPO Year | 2025 | 1998 |
Fundamental Metrics
Financial Performance| Metric | PAYP | QGEN |
|---|---|---|
| Price | $14.95 | $42.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $25.54 | ★ $45.76 |
| AVG Volume (30 Days) | 898.3K | ★ 2.4M |
| Earning Date | 08-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 7.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | $20.92 | $5.71 |
| P/E Ratio | ★ N/A | $24.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.07 | $32.53 |
| 52 Week High | $24.89 | $57.82 |
Technical Indicators
Market Signals| Indicator | PAYP | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 46.44 | 58.85 |
| Support Level | $14.72 | $42.82 |
| Resistance Level | $16.56 | $44.03 |
| Average True Range (ATR) | 0.80 | 0.87 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 18.41 | 55.93 |
Price Performance
Historical ComparisonAbout PAYP PayPay Corporation American Depository Shares
PayPay Corp is a FinTech company in Japan that operates a digital finance platform centered on payments, offering a range of payment and financial services to users and merchants. The company has two reportable segments: i) Payment segment: It includes payment settlement services and related services through its PayPay app, and credit payment settlement services such as revolving and installment payment options and cash advances; and ii) Financial service segment: It includes internet banking services, securities intermediary services and PayPay Point investment-related services, and loan management services. The majority of revenue is derived from the Payment segment. Geographically, the company's maximum revenue is generated in Japan.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).